Dr. Thomas Danne will receive the Children with Diabetes (CWD) President’s Award for Innovation on March 13. He currently serves as the Chief Medical Officer for Breakthrough T1D. This award acknowledges his extraordinary leadership in using innovation and technology for devices that help people thrive.
A Legacy of Global Diabetes Innovation
The presentation occurs today during the Advanced Technologies & Treatment for Diabetes conference in Barcelona. Dr. Danne has spent decades advancing research and global collaboration in the field. This expertise led to his selection for the Children with Diabetes (CWD) President’s Award. Previously, he led the Department of General Pediatrics at the Auf der Bult Hospital in Germany.
Furthermore, his work focuses on improving access to life-changing therapies for the T1D community. He has held leadership roles at the International Society for Pediatric and Adolescent Diabetes. Consequently, he is recognized as an international expert in pediatric endocrinology.
Breakthrough T1D remains the leading global research organization for type 1 diabetes. They celebrate Dr. Danne for his contributions to therapy development and clinical care. His vision helps move the organization toward a future without T1D, a goal supported by the Children with Diabetes (CWD) President’s Award recognition.
Moreover, the CWD President’s Award highlights professionals who drive meaningful scientific progress. Dr. Danne’s work with the SWEET Registry also demonstrates his commitment to quality care. He continues to inspire researchers and families worldwide.
Aaron Kowalski, the CEO of Breakthrough T1D, praised Dr. Danne’s long-standing dedication to the mission. He noted the significant impact of these scientific breakthroughs.
“Thomas’ many contributions to driving breakthroughs in type 1 diabetes therapy development and care have had a tremendous impact on the global type 1 diabetes community and are instrumental in moving our mission forward, faster.”
Dr. Danne remains focused on closing the gap between research and patient adoption. His leadership continues to shape the future of diabetes treatment globally.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: PRNewswire.com
